Patent appeal board takes up Ozempic challengenews2023-10-04T19:30:08+00:00October 4th, 2023|Endpoints News|
Slew of pharma industry players form coalition to push back against antitrust reformnews2023-10-04T16:51:03+00:00October 4th, 2023|Endpoints News|
Sandoz shares dip on first day of Swiss listing after Novartis spinoffnews2023-10-04T16:41:54+00:00October 4th, 2023|Endpoints News|
SomaLogic, Standard BioTools to merge into $1B multi-omics tech providernews2023-10-04T15:34:45+00:00October 4th, 2023|Endpoints News|
Freeline’s early Gaucher disease data; Shorla raises $35M; Regenxbio to start pivotal DMD trial next yearnews2023-10-04T14:45:59+00:00October 4th, 2023|Endpoints News|
Nobel Prize winner Katalin Karikó on rejection, finally being recognized and her mRNA worknews2023-10-04T12:50:42+00:00October 4th, 2023|Endpoints News|
New York Blood Center Enterprises buys Talaris’ cell therapy facilities in CDMO expansionnews2023-10-04T12:30:39+00:00October 4th, 2023|Endpoints News|
Lilly’s diabetes and obesity leader to retire in broader leadership shufflenews2023-10-04T11:26:15+00:00October 4th, 2023|Endpoints News|
Kezar Life Sciences changes CEOs, lays off 41% of staff and halts preclinical R&D to extend cash runwaynews2023-10-04T11:21:58+00:00October 4th, 2023|Endpoints News|
Moderna’s combo mRNA vaccine for Covid and flu, mRNA-1083, to enter PhIII after PhI/II successnews2023-10-04T11:00:06+00:00October 4th, 2023|Endpoints News|
